Literature DB >> 11724667

Impact of human immunodeficiency virus type 1 infection on the epidemiology and outcome of bacterial meningitis in South African children.

S A Madhi1, A Madhi, K Petersen, M Khoosal, K P Klugman.   

Abstract

OBJECTIVE: To define the impact that the human immunodeficiency virus type 1 (HIV-1) epidemic has had on the burden and outcome of bacterial meningitis in an area with a high prevalence of pediatric HIV-1 infection.
METHODS: Children less than 12 years of age with proven or suspected bacterial meningitis were enrolled in this study between March 1997 and February 1999, and their hospital records were retrospectively reviewed for clinical data.
RESULTS: Sixty-two (42.2%) of the 147 children tested for HIV-1 infection were infected. Streptococcus pneumoniae (Pnc) exceeded Haemophilus influenzae type b (Hib) as the most important cause of meningitis in HIV-1-infected (74.2% vs. 12.9%, respectively) compared with uninfected children (29.4% vs. 42.3%, respectively, P less than 10(-5)). The estimated relative risk of Pnc meningitis was greater in HIV-1-infected than in uninfected children under 2 years of age (relative risk [RR] = 40.4; 95% confidence intervals [CI] = 17.7-92.2). Overall, HIV-1-infected children had a higher rate of mortality than uninfected children (30.6% vs. 11.8%, respectively, P = 0.01), and in particular, HIV-1-infected children with Pnc meningitis (60.8% vs. 36.0%, respectively, P = 0.04) had a poorer outcome.
CONCLUSIONS: Streptococcus pneumoniae has exceeded Hib as the most important pathogen causing bacterial meningitis in HIV-1-infected compared with uninfected children. Effective vaccination against Hib and Pnc should be evaluated to reduce the overall burden of bacterial meningitis in HIV-1-infected children.

Entities:  

Mesh:

Year:  2001        PMID: 11724667     DOI: 10.1016/s1201-9712(01)90085-2

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  14 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 2.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

3.  The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi.

Authors:  E M Molyneux; M Tembo; K Kayira; L Bwanaisa; J Mweneychanya; A Njobvu; H Forsyth; S Rogerson; A L Walsh; M E Molyneux
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

4.  Risk factors for death and severe sequelae in Malawian children with bacterial meningitis, 1997-2010.

Authors:  David W McCormick; Mark L Wilson; Limangeni Mankhambo; Ajib Phiri; Yamikani Chimalizeni; Kondwani Kawaza; Brigitte Denis; Enitan D Carrol; Elizabeth M Molyneux
Journal:  Pediatr Infect Dis J       Date:  2013-02       Impact factor: 2.129

5.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

Review 6.  Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013.

Authors:  Karen H Keddy; Arvinda Sooka; Alfred Musekiwa; Anthony M Smith; Husna Ismail; Nomsa P Tau; Penny Crowther-Gibson; Frederick J Angulo; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2015-11-01       Impact factor: 9.079

7.  Bacterial meningitis and Haemophilus influenzae type b conjugate vaccine, Malawi.

Authors:  David W McCormick; Elizabeth M Molyneux
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

Review 8.  Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.

Authors:  Marta C Nunes; Shabir A Madhi
Journal:  Hum Vaccin Immunother       Date:  2012-02-01       Impact factor: 3.452

9.  Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era.

Authors:  Mathura Ravishankar; Ifunanya Dallah; Manoj Mathews; Christopher M Bositis; Musaku Mwenechanya; Lisa Kalungwana-Mambwe; David Bearden; Allison Navis; Melissa A Elafros; Harris Gelbard; William H Theodore; Igor J Koralnik; Jason F Okulicz; Brent A Johnson; Clara Belessiotis; Ornella Ciccone; Natalie Thornton; Melissa Tsuboyama; Omar K Siddiqi; Michael J Potchen; Izukanji Sikazwe; Gretchen L Birbeck
Journal:  Epilepsia Open       Date:  2022-04-01

10.  Recurrent pneumococcal meningitis in a splenectomised HIV-infected patient.

Authors:  Philippe C Morand; Veronique Veuillez; Claire Poyart; Eric Abachin; Gilles Quesne; Bertrand Dupont; Patrick Berche; Jean-Paul Viard
Journal:  Ann Clin Microbiol Antimicrob       Date:  2003-11-07       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.